|
| |
| | | 67529 | | 28.06.2021 | | Novartis Pharma Schweiz AG | | | | | | | 13.09.2028 | | | | | | 01.99. | | | | 01.99. | | FI |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | ZOLGENSMA | Solution for Infusion | (Onasemnogenum Abeparvovecum 2 ) | M09AX09 | PI | | 02 | Zolgensma | | (Onasemnogenum Abeparvovecum 20000000 Mio U) | | |
|
|
|
